ReviewFrontiers in immunology2019

The Emerging Role of Triggering Receptor Expressed on Myeloid Cells 2 as a Target for Immunomodulation in Ischemic Stroke.

Pascal Gervois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.